The amino acid sequence of Neisseria lactamica PorB surface-exposed loops influences toll-like receptor 2-dependent cell activation

Infection and Immunity

Volumn 80, Issue 10, 2012, Pages 3417-3428

  Toussi, Deana N ^a   Carraway, Margaretha ^a   Wetzler, Lee M ^a   Lewis, Lisa A ^b   Liu, Xiuping ^a   Massari, Paola ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; PORB PROTEIN; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BACTERIAL STRAIN; CELL ACTIVATION; CHIMERA; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE SEQUENCE; GENE SWITCHING; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; NEISSERIA LACTAMICA; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; CHEMOKINE CCL5; HEK293 CELLS; HUMANS; INTERLEUKIN-8; MODELS, MOLECULAR; MUTATION; NEISSERIA LACTAMICA; PORINS; PROTEIN BINDING; PROTEIN CONFORMATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2;

EID: 84867608908     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00683-12     Document Type: Article

References (64)

1. Akira S. 2003. Toll-like receptor signaling. J. Biol. Chem. 278:38105- 38108.
2. Ala'Aldeen DA, et al. 2000. Dynamics of meningococcal long-term carriage among university students and their implications for mass vaccination. J. Clin. Microbiol. 38:2311-2316.
3. Bennett JS, et al. 2010. Independent evolution of the core and accessory gene sets in the genus Neisseria: insights gained from the genome of Neisseria lactamica isolate 020-06. BMC Genomics 11:652.
4. Berube J, Bourdon C, Yao Y, Rousseau S. 2009. Distinct intracellular signaling pathways control the synthesis of IL-8 and RANTES in TLR1/ TLR2, TLR3 or NOD1 activated human airway epithelial cells. Cell Signal. 21:448-456.
5. Blake MS, Gotschlich EC. 1986. Functional and immunological properties of pathogenic neisserial surface proteins, p 377- 400. In Inouye M(ed), Bacterial outer membranes as model systems. John Wiley, New York, NY.
6. Carrol ED, Thomson AP, Jones AP, Jeffers G, Hart CA. 2005. A predominantly anti-inflammatory cytokine profile is associated with disease severity in meningococcal sepsis. Intensive Care Med. 31:1415-1419.
7. Carrol ED, Thomson AP, Mobbs KJ, Hart CA. 2000. The role of RANTES in meningococcal disease. J. Infect. Dis. 182:363-366.
8. Chenna R, et al. 2003. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res. 31:3497-3500.
9. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. 1999. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 274:10689 -10692.
10. Clamp M, Cuff J, Searle SM, Barton GJ. 2004. The Jalview Java alignment editor. Bioinformatics 20:426-427.
11. Denning DW, Gill SS. 1991. Neisseria lactamica meningitis following skull trauma. Rev. Infect. Dis. 13:216 -218.
12. Derrick JP, Urwin R, Suker J, Feavers IM, Maiden MC. 1999. Structural and evolutionary inference from molecular variation in neisseria porins. Infect. Immun. 67:2406 -2413.
13. Fowler MI, Yin KY, Humphries HE, Heckels JE, Christodoulides M. 2006. Comparison of the inflammatory responses of human meningeal cells following challenge with Neisseria lactamica and with Neisseria meningitidis. Infect. Immun. 74:6467- 6478.
14. Frasch CE, Zollinger WD, Poolman JT. 1985. Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev. Infect. Dis. 7:504 -510.
15. Gold R, Goldschneider I, Lepow ML, Draper TF, Randolph M. 1978. Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children. J. Infect. Dis. 137:112-121.
16. Halstensen A, et al. 1993. Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease. J. Infect. Dis. 167:471- 475.
17. Henriquet C, Gougat C, Combes A, Lazennec G, Mathieu M. 2007. Differential regulation of RANTES and IL-8 expression in lung adenocarcinoma cells. Lung Cancer 56:167-174.
18. Hollis DG, Wiggins GL, Weaver RE. 1969. Neisseria lactamicus sp. n., a lactose-fermenting species resembling Neisseria meningitidis. Appl. Microbiol. 17:71-77.
19. Holten E. 1979. Serotypes of Neisseria meningitidis isolated from patients in Norway during the first six months of 1978. J. Clin. Microbiol. 9:186- 188.
20. Jarva H, et al. 2007. Molecular characterization of the interaction between porins of Neisseria gonorrhoeae and C4b-binding protein. J. Immunol. 179:540 -547.
21. Jeanteur D, Lakey JH, Pattus F. 1991. The bacterial porin superfamily: sequence alignment and structure prediction. Mol. Microbiol. 5:2153- 2164.
22. Lakshminarayanan V, Drab-Weiss EA, Roebuck KA. 1998. H2O2 and tumor necrosis factor-alpha induce differential binding of the redoxresponsive transcription factors AP-1 and NF-kappaB to the interleukin-8 promoter in endothelial and epithelial cells. J. Biol. Chem. 273:32670- 32678.
23. Lambert C, Leonard N, De Bolle X, Depiereux E. 2002. ESyPred3D: prediction of proteins 3D structures. Bioinformatics 18:1250 -1256.
24. Leidal KG, Munson KL, Denning GM. 2001. Small molecular weight secretory factors from Pseudomonas aeruginosa have opposite effects on IL-8 and RANTES expression by human airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 25:186 -195.
25. Lewis LA, et al. 1999. Phase variation of HpuAB and HmbR, two distinct haemoglobin receptors of neisseria meningitidis DNM2. Mol. Microbiol. 32:977-989.
26. Li J, et al. 2002. Regulation of human airway epithelial cell IL-8 expression by MAP kinases. Am. J. Physiol. Lung Cell. Mol. Physiol. 283:L690 -L699.
27. Liu X, Wetzler LM, Massari P. 2008. The PorB porin from commensal Neisseria lactamica induces Th1 and Th2 immune responses to ovalbumin in mice and is a potential immune adjuvant. Vaccine 26:786 -796.
28. Liu X, Wetzler LM, Nascimento LO, Massari P. 2010. Human airway epithelial cell responses to Neisseria lactamica and purified porin via Tolllike receptor 2-dependent signaling. Infect. Immun. 78:5314 -5323.
29. Mackinnon FG, et al. 1999. The role of B/T costimulatory signals in the immunopotentiating activity of neisserial porin. J. Infect. Dis. 180:755- 761.
30. MacLeod H, Bhasin N, Wetzler LM. 2008. Role of protein tyrosine kinase and Erk1/2 activities in the Toll-like receptor 2-induced cellular activation of murine B cells by neisserial porin. Clin. Vaccine Immunol. 15:630-637.
31. Massari P, Gunawardana J, Liu X, Wetzler LM. 2010. Meningococcal porin PorB prevents cellular apoptosis in a toll-like receptor 2- and NFkappaB-independent manner. Infect. Immun. 78:994 -1003.
32. Massari P, et al. 2002. Cutting edge: immune stimulation by neisserial porins is toll-like receptor 2 and MyD88 dependent. J. Immunol. 168: 1533-1537.
33. Massari P, Ho Y, Wetzler LM. 2000. Neisseria meningitidis porin PorB interacts with mitochondria and protects cells from apoptosis. Proc. Natl. Acad. Sci. U. S. A. 97:9070 -9075.
34. Massari P, King CA, Macleod H, Wetzler LM. 2005. Improved purification of native meningococcal porin PorB and studies on its structure/ function. Protein Expr. Purif. 44:136 -146.
35. Massari P, et al. 2006. Meningococcal porin PorB binds to TLR2 and requires TLR1 for signaling. J. Immunol. 176:2373-2380.
36. Mayer AK, Dalpke AH. 2007. Regulation of local immunity by airway epithelial cells. Arch. Immunol. Ther. Exp. (Warsz.) 55:353-362.
37. Medzhitov R, Janeway C, Jr. 2000. The Toll receptor family and microbial recognition. Trends Microbiol. 8:452- 456.
38. Merz AJ, So M. 2000. Interactions of pathogenic neisseriae with epithelial cell membranes. Annu. Rev. Cell Dev. Biol. 16:423- 457.
39. Moller AS, et al. 2005. Chemokine patterns in meningococcal disease. J. Infect. Dis. 191:768 -775.
40. Oliver KJ, et al. 2002. Neisseria lactamica protects against experimental meningococcal infection. Infect. Immun. 70:3621-3626.
41. Olsen SF, et al. 1991. Pharyngeal carriage of Neisseria meningitidis and Neisseria lactamica in households with infants within areas with high and low incidences of meningococcal disease. Epidemiol. Infect. 106:445- 457.
42. Piet JR, et al. 2011. Genome sequence of Neisseria meningitidis serogroup B strain H44/76. J. Bacteriol. 193:2371-2372.
43. Qi HL, Tai JY, Blake MS. 1994. Expression of large amounts of neisserial porin proteins in Escherichia coli and refolding of the proteins into native trimers. Infect. Immun. 62:2432-2439.
44. Qin H, et al. 1999. Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1. Nature 399:549 -557.
45. Roebuck KA, et al. 1999. Stimulus-specific regulation of chemokine expression involves differential activation of the redox-responsive transcription factors AP-1 and NF-kappaB. J. Leukoc. Biol. 65:291-298.
46. Sayle RA, Milner-White EJ. 1995. RASMOL: biomolecular graphics for all. Trends Biochem. Sci. 20:374.
47. Schall TJ. 1991. Biology of the RANTES/SIS cytokine family. Cytokine 3:165-183.
48. Schmeck B, et al. 2006. Streptococcus pneumoniae induced c-Jun-Nterminal kinase- and AP-1-dependent IL-8 release by lung epithelial BEAS-2B cells. Respir. Res. 7:98.
49. Shaughnessy J, Lewis LA, Jarva H, Ram S. 2009. Functional comparison of the binding of factor H short consensus repeat 6 (SCR 6) to factor H binding protein from Neisseria meningitidis and the binding of factor H SCR 18 to 20 to Neisseria gonorrhoeae porin. Infect. Immun. 77:2094- 2103.
50. Singleton TE, Massari P, Wetzler LM. 2005. Neisserial porin-induced dendritic cell activation is MyD88 and TLR2 dependent. J. Immunol. 174: 3545-3550.
51. Tanabe M, Iverson TM. 2009. Expression, purification and preliminary X-ray analysis of the Neisseria meningitidis outer membrane protein PorB. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 65:996 -1000.
52. Tanabe M, Nimigean CM, Iverson TM. 2010. Structural basis for solute transport, nucleotide regulation, and immunological recognition of Neisseria meningitidis PorB. Proc. Natl. Acad. Sci. U. S. A.
53. Tettelin H, et al. 2000. Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science 287:1809 -1815.
54. Tommassen J, Vermeij P, Struyvé M, Benz R, Poolman JT. 1990. Isolation of Neisseria meningitidis mutants deficient in class 1 (Por A) and class 3 (Por B) outer membrane proteins. Infect. Immun. 58:1355-1359.
55. Urwin R, Holmes EC, Fox AJ, Derrick JP, Maiden MC. 2002. Phylogenetic evidence for frequent positive selection and recombination in the meningococcal surface antigen PorB. Mol. Biol. Evol. 19:1686 -1694.
56. van Deuren M, et al. 1995. Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections. J. Infect. Dis. 172:433- 439.
57. Visintin A, Halmen KA, Latz E, Monks BG, Golenbock DT. 2005. Pharmacological inhibition of endotoxin responses is achieved by targeting the TLR4 coreceptor, MD-2. J. Immunol. 175:6465- 6472.
58. Wanke I, et al. 2011. Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways. J. Investig. Dermatol. 131:382-390.
59. Waterhouse AM, Procter JB, Martin DM, Clamp M, Barton GJ. 2009. Jalview version 2-a multiple sequence alignment editor and analysis workbench. Bioinformatics 25:1189 -1191.
60. Wetzler LM, Ho Y, Reiser H. 1996. Neisserial porins induce B lymphocytes to express costimulatory B7-2 molecules and to proliferate. J. Exp. Med. 183:1151-1159.
61. Wilson HD, Overman TL. 1976. Septicemia due to Neisseria lactamica. J. Clin. Microbiol. 4:214 -215.
62. Yang L, et al. 2009. Distribution of surface-protein variants of hyperinvasive meningococci in China. J. Infect. 58:358 -367.
63. Yazdankhah SP, Caugant DA. 2004. Neisseria meningitidis: an overview of the carriage state. J. Med. Microbiol. 53:821- 832.
64. Zollinger WD, Moran EE, Devi SJ, Frasch CE. 1997. Bactericidal antibody responses of juvenile rhesus monkeys immunized with group B Neisseria meningitidis capsular polysaccharide-protein conjugate vaccines. Infect. Immun. 65:1053-1060.